|
Lincoln Pharmaceuticals Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
1189.67 Cr.
|
P/BV
|
1.60
|
Book Value (Rs.)
|
371.63
|
|
52 Week High/Low (Rs.)
|
677/440
|
FV/ML
|
10/1
|
P/E(X)
|
14.45
|
|
Bookclosure
|
12/09/2025
|
EPS (Rs.)
|
41.11
|
Div Yield (%)
|
0.30
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 41.11 | 46.58 | 36.40 | 34.63 | 31.11 |
| Diluted EPS (Rs.) | 41.11 | 46.58 | 36.40 | 34.63 | 31.11 |
| Cash EPS (Rs.) | 47.55 | 51.89 | 40.97 | 38.66 | 34.91 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 335.34 | 295.98 | 250.86 | 216.12 | 187.85 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 335.34 | 295.98 | 250.86 | 216.12 | 187.85 |
| Revenue From Operations / Share (Rs.) | 311.15 | 289.84 | 254.78 | 235.71 | 212.09 |
| PBDIT / Share (Rs.) | 61.89 | 67.07 | 55.76 | 52.66 | 46.42 |
| PBIT / Share (Rs.) | 55.45 | 61.76 | 51.18 | 48.62 | 42.64 |
| PBT / Share (Rs.) | 54.51 | 61.03 | 50.16 | 47.90 | 41.86 |
| Net Profit / Share (Rs.) | 41.11 | 46.58 | 36.40 | 34.63 | 31.12 |
| NP After MI And SOA / Share (Rs.) | 41.11 | 46.58 | 36.40 | 34.63 | 31.11 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 19.89 | 23.13 | 21.88 | 22.34 | 21.88 |
| PBIT Margin (%) | 17.82 | 21.30 | 20.08 | 20.62 | 20.10 |
| PBT Margin (%) | 17.51 | 21.05 | 19.68 | 20.32 | 19.73 |
| Net Profit Margin (%) | 13.21 | 16.07 | 14.28 | 14.69 | 14.67 |
| NP After MI And SOA Margin (%) | 13.21 | 16.07 | 14.28 | 14.69 | 14.66 |
| Return on Networth / Equity (%) | 12.25 | 15.73 | 14.50 | 16.02 | 16.58 |
| Return on Capital Employeed (%) | 16.07 | 20.34 | 19.89 | 21.94 | 22.10 |
| Return On Assets (%) | 10.33 | 13.32 | 12.41 | 12.97 | 13.54 |
| Asset Turnover Ratio (%) | 0.83 | 0.90 | 0.90 | 0.95 | 0.99 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 4.71 | 4.84 | 5.08 | 3.90 | 4.17 |
| Quick Ratio (X) | 3.97 | 4.00 | 4.11 | 3.10 | 3.53 |
| Inventory Turnover Ratio (X) | 8.00 | 7.89 | 2.48 | 2.66 | 2.18 |
| Dividend Payout Ratio (NP) (%) | 4.37 | 3.22 | 4.12 | 4.32 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 3.78 | 2.89 | 3.66 | 3.87 | 0.00 |
| Earning Retention Ratio (%) | 95.63 | 96.78 | 95.88 | 95.68 | 0.00 |
| Cash Earning Retention Ratio (%) | 96.22 | 97.11 | 96.34 | 96.13 | 0.00 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 65.84 | 91.70 | 55.01 | 72.68 | 59.44 |
| Interest Coverage Ratio (Post Tax) (%) | 44.74 | 64.69 | 36.91 | 48.79 | 40.86 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 1082.31 | 1159.77 | 646.08 | 574.49 | 436.11 |
| EV / Net Operating Revenue (X) | 1.74 | 2.00 | 1.27 | 1.22 | 1.03 |
| EV / EBITDA (X) | 8.73 | 8.63 | 5.79 | 5.45 | 4.70 |
| MarketCap / Net Operating Revenue (X) | 1.77 | 2.02 | 1.33 | 1.32 | 1.06 |
| Retention Ratios (%) | 95.62 | 96.77 | 95.87 | 95.67 | 0.00 |
| Price / BV (X) | 1.64 | 1.98 | 1.35 | 1.44 | 1.20 |
| Price / Net Operating Revenue (X) | 1.77 | 2.02 | 1.33 | 1.32 | 1.06 |
| EarningsYield | 0.07 | 0.07 | 0.10 | 0.11 | 0.13 |
